Back to search

Article

Liver fibrosis assessed using non-invasive markers and genetic polymorphisms (<i>PNPLA3</i>and<i>TM6SF2</i>) predisposing to liver fibrosis, is associated with hospitalization or death from heart failure: a prospective UK Biobank study

2023-08-25

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Aside from liver related complications, non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ArLD) are associated with an increased risk of cardiovascular disease (CVD). Liver fibrosis, determined via histology and non-invasive serum fibrosis markers, is associated with cardiovascular events. The association between liver fibrosis and heart failure, and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f62feda9-ab7d-5849-9229-0c435fe51fe1
DOI
10.1101/2023.08.23.23294514
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Liver fibrosis assessed using non-invasive markers and genetic polymorphisms (<i>PNPLA3</i>and<i>TM6SF2</i>) predisposing to liver fibrosis, is associated with hospitalization or death from heart failure: a prospective UK Biobank studyDOI 10.1101/2023.08.23.23294514
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis ScoresSemantic proximity
Liver disease is a significant risk factor for cardiovascular outcomes - a UK Biobank studySemantic proximity
PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD.Semantic proximity
The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants.Semantic proximity
Epidemiology, temporal trends, and fibrosis risk stratification in metabolic dysfunction-associated steatotic liver disease in UK primary care: a population-based cohort and nested case-control studySemantic proximity
Patatin-Like Phospholipase Domain-Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population.Semantic proximity
Genetic variants that associate with cirrhosis have pleiotropic effects on human traits.Semantic proximity
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.Semantic proximity
PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis.Semantic proximity
A proteo-transcriptomic map of non-alcoholic fatty liver disease signaturesSemantic proximity
Non-alcoholic fatty liver disease and heart failure: A comprehensive bioinformatics and Mendelian randomization analysis.Semantic proximity
Current Insights into Liver Fibrosis: Epidemiological Patterns, Etiopathogenesis, Clinical Correlates, and Research AgendaSemantic proximity
Select a neighboring publication to make it the new centre.